(MENAFN- ProactiveInvestors) () is to target markets in the Netherlands Belgium and Germany following the launch of its blood gas analyser in mainland Europe.
Proxima an arterial blood gas analyser was unveiled at the 35th International Symposium on Intensive Care and Emergency Medicine (ISICEM). The launch follows its debut in the UK market last September.
Used in critical care situations the new analyser allows results to be taken from a patient's bedside which better facilitates constant monitoring and rapid analysis of the results.
Knowledge gained from the product’s launch in Britain will be a major help gaining entry into these markets Sphere said.
Wolfgang Rencken chief executive added: "Europe represents a significant opportunity for sales of Proxima.
The support of our hugely experienced Medical Advisory Board and their endorsement of Proxima will assist with the sales effort and we look forward to providing further updates on developments."
Professor Michael Quintel intensive care direct at the University of Göttingen added: ”Proxima addresses some important issues in the management of unstable critically ill patients.
“The launch of this product offers some exiting new opportunities for intensive care medicine in Germany."
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.